cbdMD (YCBD) Restructuring Costs (2022)
cbdMD (YCBD) posted Restructuring Costs of $602092.0 for Q2 2022.
cbdMD (YCBD) Restructuring Costs (2022) Analysis & Trends
cbdMD has reported Restructuring Costs for 1 years, with the latest figure at $602092.0 in Q2 2022.
- Quarterly Restructuring Costs changed N/A year-over-year to $602092.0 in Q2 2022, while the trailing twelve-month figure through Sep 2023 was $602092.0 (changed 0.0% YoY) and the FY2022 annual result came in at $602092.0, changed N/A from the prior year.
- Restructuring Costs steadied at $602092.0 in Q2 2022 per YCBD's latest filing.
- Over five years, Restructuring Costs peaked at $602092.0 in Q2 2022 and troughed at $602092.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 602,092.00 |